GSC
GHDX

Ground Swell Capital’s Genomic Health, Inc. GHDX Stock Holding History

Ground Swell Capital’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-102
Closed -$3K – 2953
2014
Q2 		$3K Buy
+102
New +$2.71K 0.01% 1374

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's GHDX Position: Q3 2014 in Review

Ground Swell Capital sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 102 shares — an estimated $3K sold.

Ground Swell Capital first reported a position in GHDX in Q2 2014 and held it in 1 quarter. The position peaked at $3K in Q2 2014. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

  • Ground Swell Capital reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 102 Genomic Health, Inc. shares in Q3 2014, an estimated $3K.
  • Ground Swell Capital first reported a position in Genomic Health, Inc. in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Genomic Health, Inc. position peaked at $3K in Q2 2014.
  • 107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.